Trader consensus heavily favors no new pandemic in 2026 at 93.5% implied probability, driven by official surveillance showing only regionally contained outbreaks such as the Bundibugyo Ebola virus PHEIC in central Africa and sporadic hantavirus cases, with no evidence of sustained efficient human-to-human transmission for any novel pathogen. Current respiratory activity remains low per CDC data, and global monitoring indicates no exponential growth meeting pandemic thresholds. This aligns with historical patterns where most spillovers fail to achieve widespread dissemination. Realistic challenges include rapid antigenic shifts in avian influenza strains like H5N1 enabling sustained transmission or undetected zoonotic events overwhelming early detection, though enhanced genomic surveillance and response protocols reduce these odds as the year progresses.